An AI-first protein design company using generative models for novel proteins and gene-editing systems.

A biotechnology company focused on precision gene editing and base-editing therapeutics.

Intellia Therapeutics advances in vivo and ex vivo CRISPR/Cas9 genome editing therapies for genetic diseases. Tailored for modern biology and life science teams.

A gene-editing biotechnology company focused on CRISPR-based cell therapy and therapeutic development.

Synthego provides CRISPR genome engineering tools, kits, and engineered cells to accelerate gene editing research. Tailored for modern biology and life science teams.

Mammoth Biosciences builds CRISPR-based diagnostics and genome-editing tools leveraging novel Cas proteins. Tailored for modern biology and life science teams.

A global life science company spanning synthetic biology, gene editing support, reagents, and therapeutic services.

A nonprofit research institute with strong programs in genomics, cancer, developmental biology, and molecular mechanisms.

Merck’s MilliporeSigma division supplies reagents, kits, and production technologies for global life science research and manufacturing.

New England Biolabs supplies enzymes, cloning kits, and reagents that accelerate molecular biology, genomics, and synthetic biology.

IDT delivers custom oligos, primers, CRISPR guides, and next-gen sequencing solutions to enable precise genetic research. Tailored for modern biology and life science teams.

Twist Bioscience provides silicon-based DNA synthesis, libraries, and antibody discovery solutions for pharma and biotech teams. Trusted by global research and diagnostic programs.